DK0724885T3 - Pernasal sammensætning og pernasalt præparat indeholdende dette - Google Patents

Pernasal sammensætning og pernasalt præparat indeholdende dette

Info

Publication number
DK0724885T3
DK0724885T3 DK94930340T DK94930340T DK0724885T3 DK 0724885 T3 DK0724885 T3 DK 0724885T3 DK 94930340 T DK94930340 T DK 94930340T DK 94930340 T DK94930340 T DK 94930340T DK 0724885 T3 DK0724885 T3 DK 0724885T3
Authority
DK
Denmark
Prior art keywords
pernasal
composition
preparation containing
alcohol
drug
Prior art date
Application number
DK94930340T
Other languages
English (en)
Inventor
Katsuya Tsukuba Laborato Mukae
Mitshuiro Tsukuba La Mizumachi
Kohki Tsukuba Laboratory Itoh
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of DK0724885T3 publication Critical patent/DK0724885T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
DK94930340T 1993-10-21 1994-10-19 Pernasal sammensætning og pernasalt præparat indeholdende dette DK0724885T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28778493 1993-10-21
PCT/JP1994/001762 WO1995011042A1 (fr) 1993-10-21 1994-10-19 Composition administree par voie nasale et preparation contenant celle-ci

Publications (1)

Publication Number Publication Date
DK0724885T3 true DK0724885T3 (da) 2002-05-21

Family

ID=17721701

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94930340T DK0724885T3 (da) 1993-10-21 1994-10-19 Pernasal sammensætning og pernasalt præparat indeholdende dette

Country Status (11)

Country Link
US (1) US5789375A (da)
EP (1) EP0724885B1 (da)
KR (1) KR100217258B1 (da)
CN (1) CN1098708C (da)
AT (1) ATE214289T1 (da)
AU (1) AU681452B2 (da)
CA (1) CA2174324A1 (da)
DE (1) DE69430132T2 (da)
DK (1) DK0724885T3 (da)
ES (1) ES2171469T3 (da)
WO (1) WO1995011042A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970032844A (ko) * 1995-12-29 1997-07-22 김준웅 지속성 경비투여제제
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
EP1137401B1 (en) * 1998-12-09 2005-11-23 Chiron Corporation Administration of neurotrophic agents to the central nervous system
EP1187639A1 (en) 1999-06-04 2002-03-20 Delrx Pharmaceutical Corporation Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
US6610271B2 (en) * 2000-05-10 2003-08-26 University Of Kentucky Research Foundation System and method for intranasal administration of lorazepam
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
JP3498041B2 (ja) * 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US20040176359A1 (en) * 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
AU2004244889A1 (en) * 2003-06-06 2004-12-16 Takeda Pharmaceutical Company Limited Solid pharmaceutical preparation
US20050069929A1 (en) 2003-08-08 2005-03-31 Invitrogen Corporation Methods and compositions for seamless cloning of nucleic acid molecules
EP2287341B1 (en) 2003-12-01 2013-02-13 Life Technologies Corporation Nucleic acid molecules containing recombination sites and methods of using the same
US20060046969A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Antibacterial compositions for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
EP2457580A1 (en) * 2004-08-25 2012-05-30 The UAB Research Foundation Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US20060046962A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20090136505A1 (en) 2005-02-23 2009-05-28 Johanna Bentz Intranasal Administration of Active Agents to the Central Nervous System
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
US8124598B2 (en) * 2006-09-14 2012-02-28 Sharon Sageman 7-keto DHEA for psychiatric use
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use
EP2271347B1 (en) 2008-03-28 2016-05-11 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
US8440631B2 (en) * 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
WO2012174158A2 (en) 2011-06-14 2012-12-20 Hale Biopharma Ventures, Llc Administration of benzodiazepine
JP6941224B2 (ja) 2018-02-06 2021-09-29 イージス セラピューティクス，エルエルシー 疾患の処置のための鼻腔内エピネフリン製剤及び方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
JPH0643390B2 (ja) * 1986-04-08 1994-06-08 久光製薬株式会社 アザシクロアルカン誘導体
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US5112804A (en) * 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
CA1335076C (en) * 1987-04-01 1995-04-04 Hanna R. Kowarski Pharmaceutical composition and method for intranasal administration
JPH01160916A (ja) * 1987-12-18 1989-06-23 Tanabe Seiyaku Co Ltd ドーパミン経鼻投与製剤
JP3219096B2 (ja) * 1990-05-10 2001-10-15 ニコメド ファーマ エイエス ｎ―グリコフロール類及びｎ―エチレングリコール類を含有する医薬製剤
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation

Also Published As

Publication number Publication date
KR960705585A (ko) 1996-11-08
CA2174324A1 (en) 1995-04-27
WO1995011042A1 (fr) 1995-04-27
DE69430132D1 (de) 2002-04-18
AU7949294A (en) 1995-05-08
EP0724885B1 (en) 2002-03-13
CN1133565A (zh) 1996-10-16
DE69430132T2 (de) 2002-08-29
ATE214289T1 (de) 2002-03-15
KR100217258B1 (ko) 1999-09-01
EP0724885A1 (en) 1996-08-07
US5789375A (en) 1998-08-04
AU681452B2 (en) 1997-08-28
CN1098708C (zh) 2003-01-15
EP0724885A4 (en) 1997-06-25
ES2171469T3 (es) 2002-09-16

Similar Documents

Publication Publication Date Title
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
NO863620D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
DE3579068D1 (de) Arzneimittelenthaltende matrizen fuer einfuehrungen in zonen mit cellularen lesionen.
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
IT1261849B (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
KR910009242A (ko) 치근막 질환 치료용 서방성 조성물
DE69322251D1 (de) Medizinische zusammensetzung
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
DE69619052T2 (de) Feste, wasserfreie, pharmazeutische Zubereitungen für vaginale Verwendung
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
PH27446A (en) Compound with gastric acid inhibitory effect
KR950013513A (ko) 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제
DE69803670T2 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
KR890007728A (ko) 진통제 제조방법
SU1459215A1 (ru) Состав полимерной диффузионной матрицы для трансдермального введения лекарственных веществ
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
KR900017599A (ko) 종양 치료용 약학 조성물
KR880000094A (ko) 위염치료제
KR920700041A (ko) 치료화합물과 그의 조성 및 용도
SE8304818L (sv) Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan
KR890001549A (ko) 위염 치료제